TY  - JOUR
AU  - Gahete, Manuel D
AU  - Rincon-Fernandez, David
AU  - Duran-Prado, Mario
AU  - Hergueta-Redondo, Marta
AU  - Ibañez-Costa, Alejandro
AU  - Rojo-Sebastian, Alejandro
AU  - Gracia-Navarro, Francisco
AU  - Culler, Michael D
AU  - Casanovas, Oriol
AU  - Moreno-Bueno, Gema
AU  - Luque, Raul M
AU  - Castaño, Justo P
PY  - 2016
DO  - 10.18632/oncotarget.11076
UR  - http://hdl.handle.net/10668/10348
T2  - Oncotarget
AB  - The truncated somatostatin receptor sst5TMD4 is associated with poor prognosis in breast cancer and increases breast cancer cell malignancy. Here, we examined the cellular/molecular mechanisms underlying this association, aiming to identify new...
LA  - en
PB  - Impact Journals LLC
KW  - VEGF
KW  - Angiogenesis
KW  - Breast cancer
KW  - Somatostatin receptor
KW  - sst5TMD4
KW  - Adult
KW  - Aged
KW  - Animals
KW  - Biomarkers, tumor
KW  - Breast neoplasms
KW  - Cell line, tumor
KW  - Female
KW  - Gene expression profiling
KW  - Gene expression regulation, neoplastic
KW  - Humans
KW  - Kaplan-Meier estimate
KW  - Lymphatic metastasis
KW  - MCF-7 cells
KW  - Mice, nude
KW  - Middle aged
KW  - Mutation
KW  - Neovascularization, pathologic
KW  - Receptors, somatostatin
KW  - Transplantation, heterologous
TI  - The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients.
TY  - research article
VL  - 7
ER  -